Stéphane Horvath is a notable inventor based in La Chapelle-Saint-Mesmin, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of medicinal products aimed at treating various health conditions. With a total of 7 patents to his name, Horvath's work has had a meaningful impact on the industry.

Latest Patents

Among his latest patents is the alpha crystalline form of strontium ranelate, which is characterized by its powder X-ray diffraction diagram and a water content ranging from 22 to 24%. This innovative formulation is particularly useful in the treatment of osteoporosis and arthrosis. Another significant patent is for the β-crystalline form of ivabradine hydrochloride, which includes a process for its preparation and pharmaceutical compositions containing it. This formulation is characterized by its powder X-ray diffraction data and is beneficial as a bradycardic agent.

Career Highlights

Stéphane Horvath is currently associated with Les Laboratoires Servier, a prominent pharmaceutical company. His work at this institution has allowed him to focus on developing innovative solutions that address critical health issues. His dedication to research and development has positioned him as a key figure in the pharmaceutical landscape.

Collaborations

Throughout his career, Horvath has collaborated with esteemed colleagues such as Gérard Damien and Marie-Noëlle Auguste. These partnerships have fostered an environment of innovation and have contributed to the successful development of his patented products.

Conclusion

Stéphane Horvath's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving health outcomes. His work continues to influence the industry and offers promising solutions for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com